Integra menegaskan kembali EPS 2026 yang disesuaikan sebesar $2,40 hingga $2,50 sambil memandu pendapatan Q3 ke $410 juta-$425 juta (NASDAQ: IART)
· seekingalpha.com
Rekapitulasi laporan laba Q2 2026 Integra LifeSciences (IART): pendapatan/EPS, penegasan panduan 2026, waktu peluncuran kembali SurgiMend, valas, leverage, risiko—baca sekarang.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...